Webinar with Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors in Advanced NSCLC

We are sorry - registration for this webinar is now closed.  A podcast will be available in 3-4 weeks. 

If you would like to be placed on the waiting list, please email Denise Brock at dbrock@cancerGRACE.org.

This program is being offered as a collaboration 

 between GRACE and LUNGevity. 

GRACE is pleased to present a webinar with lung cancer expert Dr. Lecia Sequist, of Massachusetts General Hospital, on the phenomenon of acquired resistance to EGFR tyrosine kinase inhibitors in patients who demonstrate an initial favorable response.  Dr. Sequist will be covering a wide range of issues, from what is known about the mechanisms of resistance to current clinical trials and potential mechanisms for managing this clinical situation

Registration is free, but it's limited, so if you'd like to join, please click on the link below to register.

Webinar Details:

Date: March 9, 2011

Time: 3 PM EDT/12 PM (noon) PDT

Title: Dr. Lecia Sequist on Acquired Resistance to EGFR inhibitors in Advanced NSCLC

Host:       Dr. Howard (Jack) West, Medical Oncologist, Swedish Cancer Institute, Seattle, WA

Webinar presentation followed by interactive online Q&A session.